PFE
Dividend, but make it Pfizer
Pfizer’s board just declared a $0.43 third-quarter 2026 dividend on its common stock. If you’re keeping score at home, that’s the 351st straight quarterly payout—which is basically the corporate version of showing up to work with perfect attendance and a coffee in hand.
The dividend will be paid on September 1, 2026 to shareholders of record at the close of business on July 24, 2026. So yes, the cash is coming later, but the message is immediate: Pfizer wants you to know the dividend is still part of the plan.
Why investors care
This is the kind of announcement that won’t make your portfolio moon, but it does matter if you own PFE for income. Pfizer said it remains committed to maintaining—and over the longer term, growing—the dividend as part of its capital allocation strategy.
That’s a helpful signal after a stretch where the stock has had to juggle patent cliffs, pipeline headlines, and the occasional CFO soap opera. In other words: the dividend is Pfizer’s way of saying, “Relax, we still know how to return cash.”
Big picture: For income investors, this is steady-as-she-goes news. For everyone else, it’s another reminder that Pfizer is still leaning on its payout while it tries to win back some investor enthusiasm elsewhere.